155 related articles for article (PubMed ID: 27557932)
1. The emerging role of estrogen in B cell malignancies.
Ladikou EE; Kassi E
Leuk Lymphoma; 2017 Mar; 58(3):528-539. PubMed ID: 27557932
[TBL] [Abstract][Full Text] [Related]
2. VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects.
Härzschel A; Zucchetto A; Gattei V; Hartmann TN
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210016
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.
Bao Y; Cao X
Clin Rev Allergy Immunol; 2016 Jun; 50(3):301-11. PubMed ID: 26066671
[TBL] [Abstract][Full Text] [Related]
4. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract][Full Text] [Related]
5. Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.
Buchner M; Müschen M
Curr Opin Hematol; 2014 Jul; 21(4):341-9. PubMed ID: 24811161
[TBL] [Abstract][Full Text] [Related]
6. Expression and Effects of Ligand-activated Estrogen Receptors in Chronic Lymphocytic Leukemia.
Hasni MS; Yakimchuk K
Anticancer Res; 2019 Jan; 39(1):167-172. PubMed ID: 30591454
[TBL] [Abstract][Full Text] [Related]
7. Estrogen signaling: a subtle balance between ER alpha and ER beta.
Matthews J; Gustafsson JA
Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
[TBL] [Abstract][Full Text] [Related]
8. Targeting CK2-driven non-oncogene addiction in B-cell tumors.
Mandato E; Manni S; Zaffino F; Semenzato G; Piazza F
Oncogene; 2016 Nov; 35(47):6045-6052. PubMed ID: 27041560
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.
Menendez P; Vargas A; Bueno C; Barrena S; Almeida J; De Santiago M; López A; Roa S; San Miguel JF; Orfao A
Leukemia; 2004 Mar; 18(3):491-8. PubMed ID: 14724650
[TBL] [Abstract][Full Text] [Related]
10. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
12. cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.
Domka K; Goral A; Firczuk M
Front Immunol; 2020; 11():1538. PubMed ID: 32793211
[TBL] [Abstract][Full Text] [Related]
13. B-cell tumor development in
Mouly E; Ghamlouch H; Della-Valle V; Scourzic L; Quivoron C; Roos-Weil D; Pawlikowska P; Saada V; Diop MK; Lopez CK; Fontenay M; Dessen P; Touw IP; Mercher T; Aoufouchi S; Bernard OA
Blood Adv; 2018 Mar; 2(6):703-714. PubMed ID: 29581109
[TBL] [Abstract][Full Text] [Related]
14. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis.
Chen JQ; Yager JD
Ann N Y Acad Sci; 2004 Dec; 1028():258-72. PubMed ID: 15650251
[TBL] [Abstract][Full Text] [Related]
15. Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Fowler NH; Cheah CY; Gascoyne RD; Gribben J; Neelapu SS; Ghia P; Bollard C; Ansell S; Curran M; Wilson WH; O'Brien S; Grant C; Little R; Zenz T; Nastoupil LJ; Dunleavy K
Haematologica; 2016 May; 101(5):531-40. PubMed ID: 27132279
[TBL] [Abstract][Full Text] [Related]
16. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
17. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
[TBL] [Abstract][Full Text] [Related]
18. A review of the association between interleukin-10 and human B-cell malignancies.
Khatri VP; Caligiuri MA
Cancer Immunol Immunother; 1998 Jul; 46(5):239-44. PubMed ID: 9690451
[No Abstract] [Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
20. A Newly Synthetized Ferrocenyl Derivative Selectively Induces Apoptosis in ALL Lymphocytes through Mitochondrial Estrogen Receptors.
Aghvami M; Pourahmad J; Zarghi A; Eshghi P; Zarei MH; Farzaneh S; Sattari F
Anticancer Agents Med Chem; 2018; 18(7):1032-1043. PubMed ID: 29210666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
